Evaluation of Carmeda® Bioactive Surface (CBAS®),Duraflo II and a novel nonspecific protease-modified surface using a new in vitro model simulating cardiopulmonary bypass

Courtney JM , Irvine L. , Gaylor Jds , Forbes CD , Taylor KM Blood compatibility in cardiopulmonary bypass. In: Hastings GW ed. Cardiovascular biomaterials . London: Springer-Verlag, 1992: 37-79.

Forbes CD , Courtney JM Thrombosis and artificial surfaces. In: Bloom AL , Forbes CD , Thomas DP , Tuddenham EGD eds. Haemostatis and thrombosis. London : Churchill Livingstone, 1994: 1301-24.

Klinkmann H. , Falkenhagen D. , Courtney JM Clinical relevance of biocompatibility - the material cannot be divorced from the device. In: Gurland HJ ed. Uremia therapy. Berlin: Springer-Verlag , 1987: 125-38.

Courtney JM , Sundaram S. , Forbes CD Extracorporeal situations: biocompatibility aspects of the application of biomaterials. In: Forbes CD , Cushieri A eds. Management of bleeding disorders in surgical practice. Oxford: Blackwell Scientific, 1993: 236-76.

Colton CK , Ward RA , Shaldon S. Scientific basis for assessment of biocompatibility in extracorporeal blood treatment. Nephrol Dial Transplant 1994 ; 9: 11-17.

Ringoir S. , Vanholder R. An introduction to biocompatibility. Artif Organs 1986; 10: 20-27.

Bonner J. , Ritz E. Ethylene oxide (ETO) as a major cause of anaphylactoid reactions in dialysis . Artif Organs 1987; 11: 111-17.

Boisclair MD , Lane DA , Philippou H. , Sheikh S. , Hunt B. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1+2. Thromb Haemost 1993; 70: 253-58.

Brister SJ , Ofosu FA , Buchanan MR Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant? Thromb Haemostasis 1993; 70: 259-62.

Newman S. Neuropsychological and psychological changes following cardiac surgery . In: Smith PL , Taylor KM eds. Cardiac surgery and the brain. London: Edward Arnold, 1993: 34-54.

Pugsley WB Assessment of microembolic load during cardiopulmonary bypass by transcranial Doppler techniques. In: Smith PL , Taylor KM eds. Cardiac surgery and the brain . London: Edward Arnold, 1993: 159-64.

Edmunds LH Jr, Colman RW , Niewiarowski S. Blood-surface interactions during cardiopulmonary bypass. In: Friedel N , Hefzer R , Royston D eds. Blood use in cardiac surgery . New York: Springer-Verlag, 1991: 27-36.

Butler J. , Rocker GM , Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-59.

Schmidt B. Experimental test systems for the assessment of the blood compatibility of materials used in extracorporeal circuits. Nephrol Dial Transplant 1994; 9: 77-82.

Carmeda BioActive Surface. Compendium of Scientific Information, Summary of Experience. Medtronics Inc. 1991.

Larm O. , Larsson R. , Olsson P. Surface-immobilized heparin. In: Lane DA , Lindahl U eds. Heparin. Chemical and biological properties, clinical applications. Boco Raton, FL: CRC Press, 1989: 597-608.

Royston D. , Bidstrup BP , Taylor KM , Sapsford RN Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; ii: 1289-91.

Bidstrup BP , Royston D. , Sapsford RN , Taylor KM Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol) . J Thorac Cardiovasc Surg 1989; 97: 364-72.

Emerson TE Jr.Pharmacology of aprotinin and efficacy during cardiopulmonary bypass. Cardiovascular Drug Reviews 1989; 7: 127-40.

Pradhan MJ , Fleming JS , Nkere UU , Arnold J. , Wildevuur Crh , Taylor KM Clinical experience with heparin-coated cardiopulmonary bypass circuits . Perfusion 1991; 6: 235-42.

Giordano G. , Formica M. , Cavalli G. et al. Activation of neutrophil oxidative metabolism during cardiopulmonary bypass with membrane oxygenators. ASAIO Trans 1989; 35: 368-69.

Gott VL , Whiffen JO , Datton RC Heparin bonding on colloidal graphite surfaces. Science 1963; 142: 1297-98.

Wendel HP , Heller W. , Gallimore MJ , Hoffmeister HE Heparin-coated oxygenators significantly reduce contact system activation in an in-vitro cardiopulmonary bypass model. Blood Coagul Fibrinolysis 1994; 5: 673-78.

Toomasian JM , Hsu LC , Hirschl RB , Heiss KF , Hultquist KA , Bartlett RH Evaluation of Duraflo II heparin coating in prolonged extracorporeal membrane oxygenation . ASAIO Trans 1988; 34: 410-14.

Van der Kamp Kwhj , van Oeveren W. Contact, coagulation and platelet interaction with heparin treated equipment during heart surgery. I J Artif Organs 1993; 16: 836-42.

Dowling RD , Brown ME , Whittington RO , Quinlan JJ , Armitage JM Clinical cardiopulmonary bypass without systemic anticoagulation. Ann Thorac Surg 1993; 56: 1176-78.

Videm V. , Mollnes TE , Garred P. , Svennevig JL Biocomparability of extracorporeal circulation: in-vitro comparison of heparin-coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg 1991; 101: 654-60.

Videm V. , Svennevig JL , Fosse E. , Semb G. , Osterud A. , Mollnes TE Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 1992; 103: 806-13.

Jansen Pgm , Velthuis HT , Huybregts Rajm et al. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits. J Thorac Cardiovasc Surg 1995; 110: 829-34.

Mollnes TE , Videm V. , Riesenfeld J. et al. Complement activation and bioincompatibility. Clin Exp Immunol 1991; 86: 21-26.

Fritz H. , Wunderer G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Drug Res 1983; 33: 479-94.

Wachtfogel YT , Kucich U. , Hack CE et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion . J Thorac Cardiovasc Surg 1993; 106: 1-10.

Laurel Mtp , Ratnoff OD , Everson B. Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol) . J Lab Clin Med 1992; 119: 580-85.

Chan Bmc , Brash JL Adsorption of fibrinogen on glass: reversibility aspects. Journal of Colloid and Interface Science 1981; 82: 217-25.

Brash JL Protein adsorption and blood interactions. In: Szycher M ed. Biocompatibile polymers, metals, and composites . Lancaster, PA: Technomic, 1983: 35-52.